Company: LIMN
Filing Date: 2025-06-24
Form Type: S-1
Source: 0001410578-25-001432
Chunk: 3

Company: Liminatus Pharma, Inc.
Filing Date: 2025-06-24
Form: S-1
Chunk 3
---
 as Iris Parent Holding Corp.), a Delaware corporation, after giving effect to the Business Combination (as defined below), and where appropriate, our wholly-owned subsidiaries (including Liminatus Pharma, LLC) following the Closing Date (as defined below). Furthermore, unless otherwise stated or unless the context otherwise requires, references to “Iris” refer to Iris Acquisition Corp (formerly known as Tribe Capital Growth Corp I), a Delaware corporation, prior to the Closing Date, and references to “Liminatus” refer to Liminatus Pharma, LLC, a Delaware limited liability company, prior to the Closing Date. All references herein to the “Board” refer to the board of directors of the Company. In addition, in this prospectus:

| ● | “Business Combination” means the Transactions contemplated by the Business Combination Agreement and the related agreements. |

| ● | “Cantor” means Cantor Fitzgerald & Co. |

| ● | “CD47 Product” means any past and future product developed and to be developed using CD47 antibody drugs. |

| ● | “Class B Common Stock” means the Class B common stock, par value $0.0001 per share, of Iris. |

| ● | “Closing” means the closing of the Transactions. |

| ● | “Code” means the Internal Revenue Code of 1986, as amended and restated from time to time. |

| ● | “Common Stock” or “ParentCo Common Stock” means the common stock, par value $0.0001 per share, of the Company. |

| ● | “DGCL” means the General Corporation Law of the State of Delaware. |

| ● | “Effective Time” means the effective time of the Mergers. |

| ● | “Exchange Act” means the Securities Exchange Act of 1934, as amended. |

| ● | “Incentive Plan” means the Liminatus Pharma, Inc. 2025 Omnibus Equity Incentive Plan. |

| ● | “IPO” means Iris’s initial public offering, consummated on March 9, 2021, in which Iris sold 27,600,000 Iris Units at $10.00 per Iris Unit. |

| ● | “Iris Board” means the board of directors of Iris. |

| ● | “Iris Class A Common Stock” or “Iris Class A Shares” means the Class A common stock, par value $0.0001 per share, of Iris. |

2

| ● |